Clinical Programs

The clinical services provided by our nephrologists and associated clinical teams cover all aspects of kidney disease, both in the inpatient and outpatient settings. The faculty members of the Yale Section of Nephrology provide broad expertise in the diagnosis and management of acute and chronic kidney diseases. We work together as a committed clinical practice group, providing round-the-clock care for patients with renal disease or hypertension and easy accessibility to consultative services, both in our outpatient settings and the inpatient settings.

The care experience we provide is guided by five key values that drive everything we do.

• We are innovative.
  We translate leading scientific research into medical practice.
• We are human.
  We treat people, not just conditions.
• We are collaborative.
  We nurture health together, giving your care the time and attention you deserve.
• We are inquisitive.
  We’re smart enough to know that we can always know more.
• We are passionate.
  We bring our best every day; it’s not just what we do, it’s who we are.

The services proved by Yale Nephrology are comprehensive. In some circumstances, our services are chiefly consultative and collaborative, working hand-in-hand with referring providers. In other circumstances, our care is longitudinal and we frequently serve as a primary caregiver for the patient. In nearly all instances, care is multidisciplinary, involving other physicians, specialists, nurse practitioners, physician associates, skilled nurses, dietitians, and social workers.

The Nephrology clinical services cover all of its scopes and depths including:

• Kidney Stone Program is a wonderful collaboration between Nephrology (Dr. Neera Dahl) and Urology (Drs. Dinesh Singh and Piruz Motamedinia), in addition to a renal dietitian. This group provides comprehensive care to patients with complex stone disease.
• Hypertension Program at Yale New Haven Hospital is co-led by Drs. Jeffrey Turner and Aldo Peixoto, and provides consultative care not only to complex hypertensive patients, but also in the field of cardiovascular dysautonomia. The center offers opportunities for participation in clinical trials in resistant hypertension (in collaboration with the Section of Cardiovascular Disease) and neurogenic orthostatic hypotension. Other members of the program include Dr. John Chang and Mary Zorzanello, APRN.
• Inherited Kidney Disease Program provides advanced level care to patients with genetic renal disease, in particular autosomal dominant polycystic kidney disease, the most common clinically-relevant hereditary disease, affecting 1:500 to 1:1000 people. It is co-led by Dr. Stefan Somlo, a leading scientist in the field, and Dr. Neera Dahl, a national clinical leader in ADPKD. Patients have access to high-level genetic consultation and access to phase 2 and 3 trials in ADPKD. This program integrates closely with other Yale New Haven Hospital/Yale Medicine programs including notably Hepatology, Pediatrics and Genetics. Other nephrologists who are members of he program include Drs. Whitney Besse, Shuta Ishibe, Randy Luciano, Aldo Peixoto, and Elyssa Noce, APRN.
• Renal Transplantation Program is the largest in New England. Five Yale nephrologists (Drs. Richard Formica, Director, William Asch, Divyanshu Malhotra, Ethan Marin and Douglas Smith) collaborate with the extensive group of surgeons, nurse practitioners, nurse coordinators, social workers, pharmacists and other members of the Yale Transplantation Center. Patients benefit from extensive expertise as well as opportunities to participate in innovative clinical trials.